These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8579520)

  • 1. [Lipoproteins, antioxidants, and coronary cardiopathy].
    Guimarães AC
    Arq Bras Cardiol; 1995 Sep; 65(3):289-95. PubMed ID: 8579520
    [No Abstract]   [Full Text] [Related]  

  • 2. Antioxidants and atherosclerotic heart disease.
    Diaz MN; Frei B; Vita JA; Keaney JF
    N Engl J Med; 1997 Aug; 337(6):408-16. PubMed ID: 9241131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidised low density lipoprotein, antioxidants and coronary atherosclerosis.
    Gambhir DS; Gambhir JK
    Indian Heart J; 1997; 49(1):19-22. PubMed ID: 9130420
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-oxidants and coronary heart disease.
    Ubbink JB; Vermaak WJ
    S Afr Med J; 1995 Dec; 85(12):1279-81. PubMed ID: 8600584
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of free radicals in coronary atherosclerosis].
    Puddu P
    G Ital Cardiol; 1998 Nov; 28(11):1200-6. PubMed ID: 9866796
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid oxidation, vascular inflammation, and coronary atherosclerosis.
    Nilsson J
    Transplant Proc; 1993 Apr; 25(2):2063-4. PubMed ID: 8470271
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is there a relation between serum ferritin levels, oxidized LDL antibodies and vitamins and risk for coronary atherosclerosis].
    Soska V
    Vnitr Lek; 2004 Mar; 50(3):183-5. PubMed ID: 15125366
    [No Abstract]   [Full Text] [Related]  

  • 8. L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease.
    Yin WH; Chen JW; Tsai C; Chiang MC; Young MS; Lin SJ
    Clin Nutr; 2005 Dec; 24(6):988-97. PubMed ID: 16140428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New discoveries on atherosclerosis. LDL oxidation plays a central role].
    Nilsson J
    Lakartidningen; 1995 Oct; 92(40):3684-6, 3691. PubMed ID: 7564616
    [No Abstract]   [Full Text] [Related]  

  • 10. Exercise training improves low-density lipoprotein oxidability in untrained subjects with coronary artery disease.
    Ziegler S; Schaller G; Mittermayer F; Pleiner J; Mihaly J; Niessner A; Richter B; Steiner-Boeker S; Penak M; Strasser B; Wolzt M
    Arch Phys Med Rehabil; 2006 Feb; 87(2):265-9. PubMed ID: 16442983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The oxidative hypothesis of atherosclerosis and the use of antioxidants in coronary disease].
    Batlouni M
    Arq Bras Cardiol; 1997 Jan; 68(1):55-63. PubMed ID: 9334462
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental and clinical assessment of antioxidant efficacy of multicomponent antioxidant medication].
    Lankin VZ; Tikhaze AK; Konovalova GG; Lisina MO; Nezhdanova IB; Gamboeva SB; Kukharchuk VV; Belenkov IuN
    Ter Arkh; 2004; 76(8):10-5. PubMed ID: 15471387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of oxidized LDL by human atherosclerotic plaque.
    Iuliano L; Signore A; Violi F
    Circulation; 1997 Sep; 96(6):2093-4. PubMed ID: 9323116
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of oxidation of lipoproteins in the pathogenesis of atherosclerosis].
    Picard S
    Pathol Biol (Paris); 1996 Jan; 44(1):46-50. PubMed ID: 8734300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of low-density lipoproteins to oxidation in coronary bypass patients.
    de Rijke YB; Vogelezang CJ; van Berkel TJ; Princen HM; Verwey HF; van der Laarse A; Bruschke AV
    Lancet; 1992 Oct; 340(8823):858-9. PubMed ID: 1357286
    [No Abstract]   [Full Text] [Related]  

  • 16. Triglycerides and coronary risk.
    Shepherd J; Packard CJ
    Isr J Med Sci; 1996 Jun; 32(6):345-55. PubMed ID: 8682639
    [No Abstract]   [Full Text] [Related]  

  • 17. [The significance of ixidized low density lipoprotein in atherosclerosis].
    Hansen PR
    Ugeskr Laeger; 1996 May; 158(19):2706-10. PubMed ID: 8744072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
    Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
    Arch Intern Med; 2005 Mar; 165(5):510-5. PubMed ID: 15767525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 correlates with oxidized low density lipoprotein in coronary culprit plaques.
    Nishihira K; Imamura T; Ishikawa T; Yamashita A; Shibata Y; Itabe H; Kitamura K; Asada Y
    Thromb Res; 2009 Jul; 124(3):335-7. PubMed ID: 19272636
    [No Abstract]   [Full Text] [Related]  

  • 20. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.